Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ascendis Pharma A/S - American Depositary Shares
(NQ:
ASND
)
211.57
-4.01 (-1.86%)
Streaming Delayed Price
Updated: 11:33 AM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ascendis Pharma A/S - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan
↗
December 25, 2025
Ascendis Pharma (ASND) meets Mark Minervini's strict criteria, showing a powerful technical uptrend paired with explosive revenue growth over 269%.
Via
Chartmill
Why Dyne Therapeutics Stock Was Crushing it This Week
↗
November 21, 2025
The company has solid potential with its development of drugs targeting muscle disorders.
Via
The Motley Fool
Topics
Artificial Intelligence
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
November 19, 2025
European American Depositary Receipts (ADRs) have recently experienced a period of significant fluctuation, reflecting a broader climate of market volatility that has ripple across global financial...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Supply Chain
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
A Look Ahead: Ascendis Pharma's Earnings Forecast
↗
November 11, 2025
Via
Benzinga
How Do Investors Really Feel About Ascendis Pharma?
↗
August 28, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Peering Into Ascendis Pharma's Recent Short Interest
↗
July 03, 2025
Via
Benzinga
Ascendis (ASND) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
Ascendis (ASND) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
↗
November 12, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
↗
October 29, 2025
Via
Benzinga
Looking Into Ascendis Pharma AS's Recent Short Interest
↗
October 21, 2025
Via
Benzinga
Ascendis Pharma A/S - ADR (NASDAQ:ASND) Shows Strong Growth Momentum in Technical and Fundamental Analysis
↗
October 14, 2025
Ascendis Pharma (ASND) is a high-growth stock with strong technical uptrends and impressive fundamentals, including surging revenue and earnings momentum.
Via
Chartmill
Is Ascendis Pharma Gaining or Losing Market Support?
↗
June 03, 2025
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
↗
May 29, 2025
Via
Benzinga
What Does the Market Think About Ascendis Pharma AS?
↗
September 29, 2025
Ascendis Pharma AS's (NYSE: ASND) short interest as a percent of float has fallen 14.63% since its last report. According to exchange reported data, there are now 2.29 million shares sold short, which...
Via
Benzinga
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
↗
September 25, 2025
Ascendis Pharma (NASDAQ: ASND) has outperformed the market over the past 10 years by 13.64% on an annualized basis producing an average annual return of 26.77%. Currently, Ascendis Pharma has a market...
Via
Benzinga
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
↗
September 08, 2025
BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in the Phase 3 study.
Via
Benzinga
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
↗
September 08, 2025
Via
Benzinga
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
↗
September 04, 2025
Via
Benzinga
ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Technical Strength and High-Growth Momentum
↗
September 01, 2025
Ascendis Pharma (ASND) excels in both technical & fundamental momentum, meeting Minervini's Trend Template criteria for high-growth stocks poised for potential outperformance.
Via
Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
↗
August 19, 2025
Via
Benzinga
Ascendis (ASND) Q2 2025 Earnings Call Transcript
↗
August 07, 2025
Via
The Motley Fool
Topics
Earnings
What's Driving the Market Sentiment Around Ascendis Pharma?
↗
August 06, 2025
Via
Benzinga
What's Driving the Market Sentiment Around Ascendis Pharma?
↗
August 04, 2025
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
July 28, 2025
Via
Benzinga
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
↗
July 22, 2025
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
July 07, 2025
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
June 12, 2025
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
↗
May 21, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
